STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Millions		Total	GE shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges	Long-duration insurance contracts	Other capital	Retained earnings	Common stock held in treasury	Noncontrolling interests balance
Beginning balance at Dec. 31, 2022				$ (2,272)			$ (1,927)	$ (983)	$ 34,173	$ 82,983	$ (81,209)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ 2,388	$ (2,317)	706	(1,793)
Purchases											(311)
Dispositions									(619)		759
Stock-based compensation									73
Other changes	[1]								(2,898)
Net earnings (loss) attributable to the Company		$ 7,506								7,506
Dividends and other transactions with shareholders	[2]									(5,534)
Ending balance at Mar. 31, 2023		32,823	$ 31,652	(3,289)	(3,505)	4,214	(1,222)	(2,776)	30,729	84,955	(80,762)	$ 1,171
Preferred stock issued		3
Common stock issued		15
Common stock issued		15
Beginning balance at Dec. 31, 2023		28,579		(6,150)			(959)	(3,354)	26,962	86,527	(79,976)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					(35)	(200)	(453)	1,236
Purchases											(317)
Dispositions									(1,191)		1,785
Stock-based compensation									114
Other changes	[1]								2
Net earnings (loss) attributable to the Company		1,537								1,537
Dividends and other transactions with shareholders	[2]									1
Ending balance at Mar. 31, 2024		31,104	$ 29,855	$ (5,603)	$ (3,658)	$ 1,586	$ (1,412)	$ (2,119)	$ 25,887	$ 88,065	$ (78,508)	$ 1,248
Preferred stock issued		0
Common stock issued		$ 15

[1] Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.

[2] Included a $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.